A Phase I/II Study of Bevacizumab, Erlotinib and 5-Fluorouracil With Concurrent External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 15 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Fluorouracil (Primary)
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 Planned end date changed from 1 May 2010 to 1 May 2011 as reported by ClinicalTrials.gov.